Response to JAK1/2 Inhibition with Baricitinib in "Candle", "Savi" and "Candlelike" Diseases. a New Therapeutic Approach for Type I IFN-Mediated Autoinflammatory Diseases

---

Sanchez G. A. M., Reinhardt A., Ramsey S., Wittkowski H., Hashkes P. J., Murias S., ...More

ARTHRITIS & RHEUMATOLOGY, vol.69, 2017 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 69
• Publication Date: 2017
• Journal Name: ARTHRITIS & RHEUMATOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Hacettepe University Affiliated: Yes